Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

HEALTHCARE (NY: XLV )

144.80 -1.59 (-1.09%)
Official Closing Price Updated: 8:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,299,267
Open 146.50
Bid (Size) 144.57 (1)
Ask (Size) 145.22 (10)
Prev. Close 146.39
Today's Range 144.80 - 146.70
52wk Range 135.94 - 159.64
Shares Outstanding 2,595,653
Dividend Yield 1.59%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
China, Gold, Momentum Lead, But Surprisingly Savvy Investors Turn Bearish
Momentum stocks are leading the market higher, but this is much different leadership than what elevated the market in 2024. 
Via Talk Markets
Topics ETFs Stocks / Equities
Moderna’s Q4 Losses Worse Than Feared, But Revenue Beat And Cost Cuts Boost Stock — Retail Sentiment Follows
CEO Stéphane Bancel said the company remains focused on driving sales and achieving up to 10 product approvals by 2027, as well as removing nearly $1 billion in costs by the end of this year. 
Via Stocktwits

Performance

YTD
+5.22%
+5.22%
1 Month
+2.60%
+2.60%
3 Month
+2.01%
+2.01%
6 Month
-5.85%
-5.85%
1 Year
-0.56%
-0.56%

More News

Read More
CVS Showered With Upgrades, PT Hikes After Q4 Beat Powers Stock To Best Day In Over 25 Years: Retail Cheer Grows
Via Stocktwits
Biogen Stock Slides To Fresh 12-Year Lows As Profit Outlook Misses, But Retail Snaps Up The Dip
Via Stocktwits
Gilead Wins Price-Target Boosts After Solid Q4, Retail Brushes Off Medicare Reform Hit To HIV Drugs
Via Stocktwits
Communications Have More To Say
Via Talk Markets
Topics Stocks / Equities
Leading And Lagging Sectors For February 12, 2025
Via Benzinga
Beginnings And Blends: S&P 500 Sector Performance In The New Year
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
Vertex Pharma Stock Flooded With Price-Target Hikes After Upbeat Q4 Revenue, 2025 Outlook: Retail Stays Bullish
Via Stocktwits
Merck Stock Heads For 5th Day Of Losses As TD Cowen Downgrades On Gardasil Woes, But Retail Holds Strong
Via Stocktwits
Leading And Lagging Sectors For February 10, 2025
Via Benzinga
Consumers Are Driving Investors Crazy
Via Talk Markets
Topics ETFs
Five ETFs to invest in to hedge against policy uncertainty in 2025
Via Talk Markets
Topics ETFs
Leading And Lagging Sectors For February 7, 2025
Via Benzinga
Financials, Health Care Sectors Leading US Stocks Higher In 2025
Via Talk Markets
Topics ETFs
Regeneron Stock Down 30% Over Past 6 Months: Leerink Sees Buying Opportunity, Retail's On The Same Page
Via Stocktwits
Bristol-Myers Squibb Stock Slides On Weak 2025 Outlook, Retail Steps In To Buy The Dip
Via Stocktwits
Leading And Lagging Sectors For February 6, 2025
Via Benzinga
Eli Lilly's Blockbuster Obesity Drugs Miss Sales Estimates Again, But Investors Cheer Q4 Earnings Beat
Via Stocktwits
Leading And Lagging Sectors For February 5, 2025
Via Benzinga
Merck Retail Traders See Buying Opportunity As Stock Dives Toward Worst Day in 17 Years On Weak Guidance
Via Stocktwits
Pfizer's Retail Traders Cheer Better-Than-Expected Q4 Even As Stock Dips: ‘Another Beat And Still Crazy Cheap'
Via Stocktwits
Leading And Lagging Sectors For February 4, 2025
Via Benzinga
Can Biotech Stocks Survive The Precarious Macro?
Via Talk Markets
Topics Stocks / Equities World Trade
Exposures Tariff
Leading And Lagging Sectors For February 3, 2025
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.